Cannara Biotech Inc. (TSXV: LOVE) is a vertically integrated producer of premium‐grade cannabis and cannabis‐derivative products for the Quebec and Canadian markets. The Company’s main focus is to deliver craft‐quality “AAAA” products at disruptive retail pricing, continuous rotation of rare genetics, community responsiveness and transparency to collectively add to its value proposition. Leveraging the provinces low electricity and labor rates, Cannara owns two mega Quebec‐ based facilities spanning over 1,650,000 sq. ft., providing up to 125,000kg of annualized cultivation output.
Company Details
- Employees
- 138
- Founded
- -
- Address
- 333 Boulevard Décarie, Suite 200,canada
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cannara.ca
- Keywords
- Cannabis, THC/CBD derivative products, vertically integrated, publicly traded company, Cannabis extracts, cannabis flower, Canadian Cannabis, Cannabis Licensed Producer, Cannabis Company, Produits dérivés du THC/CBD, Intégration verticale, société cotée en bourse, extraits de cannabis, fleurs de cannabis, cannabis canadien, Pré-rouleaux de cannabis, Société de cannabis, Producteur agréé de cannabis.
- HQ
- Montréal, Québec
Cannara Biotech Inc. Questions
Cannara Biotech Inc.'s website is cannara.ca
Cannara Biotech Inc.'s LinkedIn profile is https://ca.linkedin.com/company/cannarabiotech
Cannara Biotech Inc. has
138 employees.
View email and phone details for 138
employees at Cannara Biotech Inc..
Cannara Biotech Inc.'s industry is
Biotechnology Research
Cannara Biotech Inc.'s top competitors are
Mtl Cannabis,
Pure Sunfarms,
Carmel Cannabis,
Bzam,
Organigram Global,
Rubicon Organics™,
Weed Me Inc.,
Canopy Growth Corporation,
Decibel Cannabis Company,
Aurora Cannabis Inc..
Cannara Biotech Inc.'s categories are Biotechnology Research
Cannara Biotech Inc.'s founding year is 2018
